Skip to content

Dry Needling Versus Strain-counterstrain on the Upper Trapezius

Dry Needling Versus Strain Counterstrain Technique: Pilot Study Comparing Effects Over the Upper Trapezius Myofascial Trigger Point

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01290653
Acronym
DNJ
Enrollment
39
Registered
2011-02-07
Start date
2011-02-28
Completion date
2011-09-30
Last updated
2014-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neck Pain

Brief summary

This study investigates the effect of two different techniques (dry needling and Strain-counterstrain manual technique) on the upper trapezius myofascial trigger point (MTP). Subjects with active or latent MTP in this location of the muscle will be identified and will be randomly assigned to one out of three groups: dry needling, strain-counterstrain or placebo manual technique. Pain pressure threshold, provoked pain, pain at rest, neck disability and electromyography (EMG) activity of the upper trapezius will be registered before and after six sessions of treatment.

Interventions

OTHERDry needling

Deep dry needling until achieving twitch response of the muscle

OTHERStrain-counterstrain technique

A manual technique to release tension of painful muscles.

OTHERPlacebo manual technique

A placebo technique, consisting of manual contact of the therapist with the patient without any further therapeutic approach

Sponsors

Cardenal Herrera University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Active myofascial trigger point at the upper trapezius

Exclusion criteria

* Diagnosed fibromyalgia * Cervical radiculopathy * Facial neuralgia * Coagulation alteration * Cancer * Allergy (included needles) * History of cervical or shoulder surgery * History of deep venous thrombosis * History of myopathy * History of infiltration at upper trapezius trigger point * Anticoagulant medication * Aspirin intake during the last 3 days * Drug intake (AINES, narcotics, antiepileptics, or any other analgesic medication) * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Pain Pressure Threshold6 sessionsAmount of pressure (Kg/cm2) applied at the myofascial trigger point site that elicit pain for the patient will be reported. Analogy pressure algometer(Wagner, FPK 20) will be used.

Secondary

MeasureTime frameDescription
Pain at rest6 sessionsVisual Analogue Scale
Neck Disability6 sessionsNeck Disability Index
Electromyographic activity of the upper trapezius6 sessionsSurface EMG will be recorded (MP 100 de BIOPAC Systems; Goleta, California, USA). Electrodes will be located to register activity of the Upper trapezius, according to Surface ElectroMyoGraphy for the Non-Invasive Assessment of Muscles (SENIAM) guidelines. Microvolts of activity at rest will be recorded. Data will be normalized through calculation of maximal voluntary contraction, so that final data will be reported as a percentage.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026